David Gutstein

David Gutstein is the Vice President of Strategic Program Direction in Translational & Clinical Sciences Hematology at Regeneron Pharmaceuticals, Inc., where they focus on developing therapies for coagulation and rare diseases. They began their career as a cardiologist and later became a physician investigator, combining clinical insight with scientific innovation. With a strong foundation in medicine from institutions like Northwestern University and Harvard Medical School, their experience spans multiple leading roles, including significant positions at Mount Sinai Health System, NYU Langone Medical Center, and Merck. David is guided by a commitment to understanding patient needs and translating that knowledge into meaningful therapeutic advancements.